Decreased Risk of Esophageal Adenocarcinoma after Gastric Bypass Surgery in a Cohort Study from 3 Nordic Countries

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: The objective of this study was to test the hypothesis that bariatric surgery decreases the risk of esophageal and cardia adenocarcinoma. Background: Obesity is strongly associated with esophageal adenocarcinoma and moderately with cardia adenocarcinoma, but whether weight loss prevents these tumors is unknown. Methods: This population-based cohort study included patients with an obesity diagnosis in Sweden, Finland, or Denmark. Participants were divided into a bariatric surgery group and a nonoperated group. The incidence of esophageal and cardia adenocarcinoma (ECA) was first compared with the corresponding background population by calculating standardized incidence ratios (SIR) with 95% CIs. Second, the bariatric surgery group and the nonoperated group were compared using multivariable Cox regression, providing hazard ratios (HR) with 95% CI, adjusted for sex, age, comorbidity, calendar year, and country. Results: Among 748,932 participants with an obesity diagnosis, 91,731 underwent bariatric surgery, predominantly gastric bypass (n=70,176; 76.5%). The SIRs of ECA decreased over time after gastric bypass, from SIR=2.2 (95% CI, 0.9-4.3) after 2 to 5 years to SIR=0.6 (95% CI, <0.1-3.6) after 10 to 40 years. Gastric bypass patients were also at a decreased risk of ECA compared with nonoperated patients with obesity [adjusted HR=0.6, 95% CI, 0.4-1.0 (0.98)], with decreasing point estimates over time. Gastric bypass was followed by a strongly decreased adjusted risk of esophageal adenocarcinoma (HR=0.3, 95% CI, 0.1-0.8) but not of cardia adenocarcinoma (HR=0.9, 95% CI, 0.5-1.6), when analyzed separately. There were no consistent associations between other bariatric procedures (mainly gastroplasty, gastric banding, sleeve gastrectomy, and biliopancreatic diversion) and ECA. Conclusions: Gastric bypass surgery may counteract the development of esophageal adenocarcinoma in morbidly obese individuals.

Cite

CITATION STYLE

APA

Hardvik Åkerström, J., Santoni, G., Von Euler Chelpin, M., Chidambaram, S., Markar, S. R., Maret-Ouda, J., … Lagergren, J. (2023). Decreased Risk of Esophageal Adenocarcinoma after Gastric Bypass Surgery in a Cohort Study from 3 Nordic Countries. Annals of Surgery, 278(6), 904–909. https://doi.org/10.1097/SLA.0000000000006003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free